Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Head

Showing results (131-140 of 139) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 139 results.
Journal of Medicinal Chemistry|July 12, 2002
Discovery of aminopyridine-based inhibitors of bacterial enoyl-ACP reductase (FabI)William H Miller, Mark A Seefeld, Kenneth A Newlander, et al.
Journal of Chemical Information and Modeling|November 18, 2021
High-Throughput Virtual Screening and Validation of a SARS-CoV-2 Main Protease Noncovalent InhibitorAustin Clyde, Stephanie Galanie, Daniel W Kneller, et al.
Chemistry & Biology|February 23, 2011
Discovery and characterization of a cell-permeable, small-molecule c-Abl kinase activator that binds to the myristoyl binding siteJingsong Yang, Nino Campobasso, Mangatt P Biju, et al.
Nature Chemical Biology|March 26, 2013
Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding groupMercedes Lobera, Kevin P Madauss, Denise T Pohlhaus, et al.
Nature Communications|March 28, 2023
Potent and selective covalent inhibition of the papain-like protease from SARS-CoV-2Brian C Sanders, Suman Pokhrel, Audrey D Labbe, et al.
The Journal of Biological Chemistry|May 24, 2000
Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionalityD Lee, S A Long, J L Adams, et al.
Journal of Medicinal Chemistry|March 3, 2006
Structure activity relationships of 5-, 6-, and 7-methyl-substituted azepan-3-one cathepsin K inhibitorsDennis S Yamashita, Robert W Marquis, Ren Xie, et al.
Antimicrobial Agents and Chemotherapy|September 18, 2002
Discovery of a novel and potent class of FabI-directed antibacterial agentsDavid J Payne, William H Miller, Valerie Berry, et al.
Journal of Medicinal Chemistry|January 5, 2007
Discovery of aminofurazan-azabenzimidazoles as inhibitors of Rho-kinase with high kinase selectivity and antihypertensive activityRobert A Stavenger, Haifeng Cui, Sarah E Dowdell, et al.
Pageof 14

Showing results (131-140 of 139) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 139 results.
Journal of Medicinal Chemistry|July 12, 2002
Discovery of aminopyridine-based inhibitors of bacterial enoyl-ACP reductase (FabI)William H Miller, Mark A Seefeld, Kenneth A Newlander, et al.
Journal of Chemical Information and Modeling|November 18, 2021
High-Throughput Virtual Screening and Validation of a SARS-CoV-2 Main Protease Noncovalent InhibitorAustin Clyde, Stephanie Galanie, Daniel W Kneller, et al.
Chemistry & Biology|February 23, 2011
Discovery and characterization of a cell-permeable, small-molecule c-Abl kinase activator that binds to the myristoyl binding siteJingsong Yang, Nino Campobasso, Mangatt P Biju, et al.
Nature Chemical Biology|March 26, 2013
Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding groupMercedes Lobera, Kevin P Madauss, Denise T Pohlhaus, et al.
Nature Communications|March 28, 2023
Potent and selective covalent inhibition of the papain-like protease from SARS-CoV-2Brian C Sanders, Suman Pokhrel, Audrey D Labbe, et al.
The Journal of Biological Chemistry|May 24, 2000
Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionalityD Lee, S A Long, J L Adams, et al.
Journal of Medicinal Chemistry|March 3, 2006
Structure activity relationships of 5-, 6-, and 7-methyl-substituted azepan-3-one cathepsin K inhibitorsDennis S Yamashita, Robert W Marquis, Ren Xie, et al.
Antimicrobial Agents and Chemotherapy|September 18, 2002
Discovery of a novel and potent class of FabI-directed antibacterial agentsDavid J Payne, William H Miller, Valerie Berry, et al.
Journal of Medicinal Chemistry|January 5, 2007
Discovery of aminofurazan-azabenzimidazoles as inhibitors of Rho-kinase with high kinase selectivity and antihypertensive activityRobert A Stavenger, Haifeng Cui, Sarah E Dowdell, et al.
Pageof 14